Celularity Inc financial data

Symbol
CELU, CELUW on Nasdaq
Industry
Pharmaceutical Preparations
Location
170 Park Ave, Florham Park, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
GX Acquisition Corp. (to 7/19/2021)
Latest financial report
10-Q - Q3 2024 - Dec 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 27 % -19.3%
Quick Ratio 5.89 % -23.7%
Debt-to-equity 371 % +181%
Return On Equity -120 % +17.1%
Return On Assets -25.4 % +59.2%
Operating Margin -32.7 % +97.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.5M shares -88.4%
Common Stock, Shares, Outstanding 22M shares -88.6%
Common Stock, Value, Issued 2K USD -89.5%
Weighted Average Number of Shares Outstanding, Basic 22M shares +16.7%
Weighted Average Number of Shares Outstanding, Diluted 22M shares +16.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 48.2M USD +226%
Cost of Revenue 3.88M USD +7.8%
Research and Development Expense 13.3M USD -68.2%
Operating Income (Loss) -15.8M USD +91.6%
Nonoperating Income (Expense) -19.3M USD -387%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -35M USD +80.7%
Income Tax Expense (Benefit) 10K USD -23.1%
Net Income (Loss) Attributable to Parent -35.1M USD +80.7%
Earnings Per Share, Basic -1.26 USD/shares +88.2%
Earnings Per Share, Diluted -1.26 USD/shares +88.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 133K USD -51.3%
Inventory, Net 3.96M USD -19.7%
Assets, Current 14.5M USD -12.1%
Property, Plant and Equipment, Net 63.2M USD -10.5%
Operating Lease, Right-of-Use Asset 10.9M USD -1.58%
Intangible Assets, Net (Excluding Goodwill) 9.62M USD -16.7%
Goodwill 7.35M USD 0%
Other Assets, Noncurrent 287K USD -18.9%
Assets 129M USD -18%
Accounts Payable, Current 15.4M USD +19.1%
Contract with Customer, Liability, Current 3.69M USD +50.2%
Liabilities, Current 76.2M USD -10%
Contract with Customer, Liability, Noncurrent 2.64M USD -14.8%
Deferred Income Tax Liabilities, Net 9K USD 0%
Operating Lease, Liability, Noncurrent 26.5M USD +1.45%
Other Liabilities, Noncurrent 283K USD -4.39%
Liabilities 112M USD -12.1%
Retained Earnings (Accumulated Deficit) -886M USD -4.12%
Stockholders' Equity Attributable to Parent 17.3M USD -42.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 17.3M USD -42.9%
Liabilities and Equity 129M USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.4M USD +70.6%
Net Cash Provided by (Used in) Financing Activities 6.23M USD -51.2%
Net Cash Provided by (Used in) Investing Activities -39K USD +98.8%
Common Stock, Shares Authorized 730M shares 0%
Common Stock, Shares, Issued 22M shares -88.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.79M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.3M USD -31.8%
Operating Lease, Liability 26.5M USD +1.45%
Payments to Acquire Property, Plant, and Equipment 39K USD -81.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.3M USD +79.2%
Lessee, Operating Lease, Liability, to be Paid 99.7M USD -3.26%
Property, Plant and Equipment, Gross 95.2M USD -1.09%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.53M USD +2.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.45M USD +2.19%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 73.2M USD -4.86%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.6M USD +2.07%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.67M USD +2.06%
Operating Lease, Payments 845K USD +18.2%
Additional Paid in Capital 904M USD +2.79%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.93M USD -12%
Depreciation, Depletion and Amortization 2.16M USD -8.76%
Share-based Payment Arrangement, Expense 12.2M USD -22.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%